The $800 Million Pill

Description:

"Drug companies insist that [prescription drug] prices reflect the millions they invest in research and development ... Merrill Goozner contends that American taxpayers are in fact footing the bill twice: once by supporting government-funded research and again by paying high prices for prescription drugs. Goozner demonstrates that almost all of the important and life-saving new drugs of the past quarter-century actually originated from research at taxpayer-funded universities and the National Institutes of Health ... [Goozner] suggests ways that the government's role in testing new medicines could be expanded to eliminate private-sector waste driving up the cost of existing drugs--p. [2] of jacket.

subjects: Drug Industry,  Médicaments,  Forschungsfinanzierung,  Prescription pricing,  Éducation,  Drugs,  E ducation,  Arzneimittelpreis,  Arzneimittelforschung,  Industrie pharmaceutique,  Me dicaments,  Prices,  Öffentliche Förderung,  Pharmazeutische Industrie,  Forschungsausgaben,  O ffentliche Fo rderung,  Economics,  Staatliche Einrichtung,  Pharmaceutical industry,  Consumer education,  Consommateurs,  Prix,  Drug Therapy,  Biomedical Research,  Drug development,  Drugs, prices